Press Releases

Fourth Quarter revenue increases to $27.3 millionFourth quarter profitability grows to $2.2 million or $0.15/shareSubsidiaries to open in Japan, Australia and CanadaBOTHELL, WA, February 12, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced increased revenue, gross margin and net income for the fourth quarter ended December 31, 2003 as compared with the fourth quarter of 2002.Revenue in the fourth quarter of 2003 grew to $27.3 million, a 9 percent increase over the fourth quarter of 2002. For the full year 2003, revenue increased 16 percent to $84.8 million compared with $73.0 million in 2002.The Company reported that net income increased 158 percent to $2.2 million or $0.15 per share for the fourth quarter of 2003 compared with $0.9 million or $0.06 per share in the prior year quarter. For the full year 2003, Sonosite reported a net loss of $1.8 million or $0.12 per share versus a net loss of $7.7 million or $0.59 per share for 2002. As of December 31, 2003, cash, cash equivalents and investments totaled $61.0 million.

BOTHELL, January 28, 2004 - Sonosite, Inc. (NASDAQ: SONO), the leader in high-performance, hand-carried ultrasound technology, today announced the appointment of Robert G. Hauser, M.D., F.A.C.C., president, Cardiovascular Services Division of Abbot Northwestern Hospital, to its board of directors."We are delighted that Dr. Hauser, a prominent cardiologist and accomplished executive, has joined our board," said Kevin M. Goodwin, president and CEO of Sonosite. "Dr. Hauser's broad business experience and expertise in cardiovascular medicine will play a crucial role in advising the company on growth strategies as we extend our technology and sales efforts further into key markets."In addition to his position as president of the Cardiovascular Services Division at Abbot Northwestern, Dr. Hauser, 64, is a senior consulting cardiologist at the Minneapolis Heart Institute. He was formerly the director of Pacemaker Surveillance Clinic, Minneapolis Heart Institute and served as president of the Minneapolis Heart Institute. Prior to that, Dr. Hauser served as chief executive officer of Minneapolis Cardiology Associates. He also served as president and chief executive officer of Cardiac Pacemakers, Inc. from 1988 to 1991, and continued as its Chairman and CEO until 1992 following its acquisition by Guidant.

Vascular imaging and connectivity highlighted; expanded features available mid-December CHICAGO, IL, December 1, 2003 - Sonosite, Inc. (NASDAQ: SONO), the leader in high-performance, compact ultrasound technology, is featuring enhancements to the TITAN, its next generation ultrasound system, at the 89th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) taking place this week at McCormick Place in Chicago (Booth #3944).

Introduced earlier this year, the TITAN system is a high-resolution, compact ultrasound system that addresses a broad range of clinical needs for radiology. Weighing only 7.7 pounds, the TITAN system is ergonomic in design and boots up in less than 12 seconds, making it easy for sonographers to operate wherever and whenever it is needed.

"TITAN has already become an integral part of our radiology department," said Dr. Peter Cooperberg, FRCP(C), professor and vice-chairman of Radiology, University of British Columbia. "Its compact size makes...

Third Quarter Per Share Loss Reduced to $0.01 from loss of $0.17 in 2002 BOTHELL, WA, October 30, 2003 - Sonosite, Inc. (Nasdaq: SONO), a leading point-of-care ultrasound company, today announced increased revenue and gross margins as well as a reduced loss for the third quarter and nine months ended September 30, 2003.As the Company previously projected in a news release issued on October 13, 2003, Sonosite reported third quarter revenue of $20.2 million, an increase of 10 percent, compared with $18.5 million for the third quarter of 2002. For the nine months of 2003, revenue grew 20 percent to $57.5 million compared with $47.9 million for the same period in the prior year.The Company reported a net loss of $0.2 million, or $0.01 per share, versus a net loss of $2.4 million, or $0.17 per share, for the third quarter of 2002. Earnings per share results were modestly better than projected due to a favorable foreign exchange rate gain. For the nine months, the Company's loss narrowed to $4.0 million, or $0.28 per share, versus a loss of $8.6 million, or $0.68 per share for the same period a year earlier. As of September 30, 2003, cash, cash equivalents and investments totaled $61.6 million.